RESUMEN
PURPOSE: In recent years artificial intelligence (AI), as a new segment of computer science, has also become increasingly more important in medicine. The aim of this project was to investigate whether the current version of ChatGPT (ChatGPT 4.0) is able to answer open questions that could be asked in the context of a German board examination in ophthalmology. METHODS: After excluding image-based questions, 10 questions from 15 different chapters/topics were selected from the textbook 1000 questions in ophthalmology (1000 Fragen Augenheilkunde 2nd edition, 2014). ChatGPT was instructed by means of a so-called prompt to assume the role of a board certified ophthalmologist and to concentrate on the essentials when answering. A human expert with considerable expertise in the respective topic, evaluated the answers regarding their correctness, relevance and internal coherence. Additionally, the overall performance was rated by school grades and assessed whether the answers would have been sufficient to pass the ophthalmology board examination. RESULTS: The ChatGPT would have passed the board examination in 12 out of 15 topics. The overall performance, however, was limited with only 53.3% completely correct answers. While the correctness of the results in the different topics was highly variable (uveitis and lens/cataract 100%; optics and refraction 20%), the answers always had a high thematic fit (70%) and internal coherence (71%). CONCLUSION: The fact that ChatGPT 4.0 would have passed the specialist examination in 12 out of 15 topics is remarkable considering the fact that this AI was not specifically trained for medical questions; however, there is a considerable performance variability between the topics, with some serious shortcomings that currently rule out its safe use in clinical practice.
Asunto(s)
Evaluación Educacional , Oftalmología , Consejos de Especialidades , Oftalmología/educación , Evaluación Educacional/métodos , Evaluación Educacional/normas , Alemania , Humanos , Competencia Clínica/normas , Certificación , Inteligencia ArtificialRESUMEN
The anti-vascular endothelial growth factor (anti-VEGF) agent brolucizumab has been approved in the USA in October 2019 and in Europe in February 2020 for the treatment of neovascular age-related macular degeneration (nAMD). The approval was based on the randomized, double-blind phase III studies HAWK and HARRIER with a total of 1817 patients. Brolucizumab 6â¯mg (administered every 12 or 8 weeks depending on the activity of the disease) showed a non-inferior efficacy in terms of best-corrected visual acuity compared to aflibercept 2â¯mg (administered every 8 weeks). Initial reports on the use of brolucizumab after its approval in the USA indicated a safety signal of rare adverse events termed as retinal vasculitis and/or retinal vascular occlusion that may result in severe loss of vision. Typically, these events occurred in the presence of intraocular inflammation (IOI). A safety review committee (SRC) subsequently carried out an independent analysis of data from the pivotal studies. This article sets out the current state of knowledge and aims to provide users with orientation-from the authors' perspective-in treating brolucizumab-associated IOI. It appears mandatory to provide patients with information about possible symptoms of IOI. Even though the case reports and the SRC review of HAWK/HARRIER may not yet provide sufficient evidence for any final conclusions, it seems crucial to educate patients about signs and symptoms to ensure an early detection and diagnosis in cases of IOI. Once a patient is diagnosed with IOI, retinal vasculitis, and/or retinal vascular occlusive events, physicians should act promptly with an adequate and intensive anti-inflammatory treatment and brolucizumab treatment should be discontinued. It is important to note that these recommendations are primarily based on the authors' expert opinions and should be considered as guidance in managing these events rather than a formal protocol or guidelines.
Asunto(s)
Inhibidores de la Angiogénesis , Receptores de Factores de Crecimiento Endotelial Vascular , Inhibidores de la Angiogénesis/uso terapéutico , Anticuerpos Monoclonales Humanizados , Humanos , Inflamación/tratamiento farmacológico , Inyecciones Intravítreas , Ensayos Clínicos Controlados Aleatorios como Asunto , Proteínas Recombinantes de Fusión , Agudeza VisualRESUMEN
BACKGROUND: At present minimum nursing staff numbers have been defined and are being implemented. In December 2019 the German Medical Association asked the German professional associations about their general experience with planning of medical personnel in hospital departments. As no structured data were available on this subject, the German Ophthalmological Society (DOG) founded a working group in March 2020 to answer this request. METHOD: In the course of several consensus meetings, the working group on personnel planning for physicians in hospitals of the DOG prepared a questionnaire on previous experiences in personnel planning of eye hospitals, which was sent to the heads of all university eye hospitals and departments of ophthalmology in Germany. The questionnaire consisted of individual items with fixed choices and free answers regarding the procedure and current situation of staffing as well as the range of tasks and organization of the medical service. RESULTS: Out of 104 departments 53 (51%) responded, of which 25 were from university departments (64% response), 23 from departments of other public or non-profit ownership (46%) and 5 from departments with private hospital ownership (33%). Of these 49% stated that there was no transparent basis for calculation of the number of medical positions in their hospital. Of the surveyed departments, outpatient tasks, services and revenues were considered in the calculations in only 47%. There was a statistically significant higher ratio of full-time personnel to the numbers of beds in university departments compared to private and publicly owned non-profit institutions (pâ¯< 0.001, ttest). All departments have to cope with multiple additional tasks in addition to clinical patient care, which are taken into account only to a limited extent in the staffing. Approximately 70% of the departments provide a 24â¯h/7 day (24/7) medical on-call service on site, 91% have a 24/7 surgery on-call service and 34% have a cooperation with emergency services run by the Association of Statutory Health Insurance Physicians. CONCLUSION: The results show how heterogeneously and nontransparent German departments of ophthalmology are staffed in terms of medical doctors. On average, university departments have higher personnel resources per hospital bed to cope with additional tasks in research and teaching. Outpatient tasks, which contribute significantly to the revenues of an eye department, and multiple other tasks are often not taken into account in the personnel calculation. A transparent and uniform basis for calculation of the medical staff of the departments is desirable in order to achieve a sufficient personnel staffing for a patient and employee-oriented working environment.
Asunto(s)
Oftalmología , Alemania , Departamentos de Hospitales , Humanos , Asignación de Recursos , Recursos HumanosRESUMEN
BACKGROUND: There is evidence that additional internal limiting membrane (ILM) removal reduces the recurrence rate after pucker surgery with a similar functional outcome. On the other hand, morphological changes of the inner retinal layers after ILM peeling have been described. The aim of this study was to compare the long-term data after vitrectomy with and without ILM delamination in order to uncover possible differences in morphological and functional results. METHODS: In a prospective study of 32 patients with idiopathic epiretinal membrane, 16 patients were randomized into each of 2 groups. Both groups underwent pars plana vitrectomy (ppV) with peeling of the epiretinal membrane. In group 1 no forced additional peeling of the ILM was performed and in group 2 the ILM or ILM residues were additionally removed after staining. The investigated parameters were visual acuity, central retinal thickness (CRT) in optical coherence tomography (OCT), metamorphopsia and surgical complications. The time points of the examinations were directly preoperative, after 1, 3 and 6 months and partly 8.4 years postoperatively. RESULTS: In group 1 (nâ¯= 15) the preoperative mean visual acuity improved from 0.54â¯logMAR to 0.38â¯logMAR after 6 months postoperatively (nâ¯= 13). Of this group 6 patients could be examined in the long-term course and the visual acuity improved further to 0.32â¯logMAR after 8 years. The CRT decreased from 473⯵m preoperatively to 235⯵m in the long-term interval. In group 2 (nâ¯= 15) the mean visual acuity preoperatively was 0.47â¯logMAR and improved 6 months postoperatively (nâ¯= 13) to 0.38â¯logMAR and in the long-term examination (nâ¯= 5) to 0.1â¯logMAR. The CRT in this group decreased from 417⯵m preoperatively to 278⯵m in the long-term interval. In group 1 one recurrence occurred in the follow-up period, in group 2 none. CONCLUSION: The study showed that there was no significant difference in visual acuity and CRT between the two groups neither after 6 months nor after 8 years of follow-up. The observed recurrence in the group without ILM delamination underlines the assumption that additional ILM peeling could reduce the recurrence rate.
Asunto(s)
Membrana Epirretinal , Membrana Basal , Humanos , Estudios Prospectivos , Estudios Retrospectivos , Tomografía de Coherencia Óptica , Resultado del Tratamiento , VitrectomíaRESUMEN
INTRODUCTION: Central serous chorioretinopathy (CSC) is the fourth most common cause of vision loss without an evidence-based treatment recommendation. A positive effect of micropulse laser (MPL) treatment has been described in the literature in recent years. This study aimed to reappraise these results in a patient population with chronic CSC. METHODS: Patients suffering from chronic CSC with a source point detectable in fluorescein angiography (longer than 3 months duration and unresponsive to treatment with eplerenone and carbonic anhydrase inhibitors) were identified and included in this prospective and consecutive case study. Patients were controlled with a yellow laser (577â¯nm) after 6 weeks, 12 weeks and then every 3 months. RESULTS: A total of 28 patients were included (28 eyes). The mean duration of anamnesis was 444 days (90-1412 days) and the mean duration of the observation period after MPL was 257 days (42-909 days). The foveal retinal thickness measured 351.7⯱ 82.4⯵m before, compared to 253.6⯱ 86.48⯵m after MPL (mean of all patients over the whole observation period). Visual acuity was 0.33⯱ 0.21â¯logMAR prior to MPL and 0.30⯱ 0.22â¯logMAR posttreatment. Of the patients two underwent a second MPL and three patients underwent photodynamic treatment (PDT) after insufficient clinical improvement and were consequently excluded from the study. CONCLUSION: Retinal thickness in this patient population with chronic CSC was significantly reduced after MPL treatment with no significant changes of visual acuity. No side effects of MPL were observed. Larger studies including control groups are warranted to quantify the effects of MPL further.
Asunto(s)
Coriorretinopatía Serosa Central , Fotoquimioterapia , Enfermedad Crónica , Angiografía con Fluoresceína , Humanos , Fármacos Fotosensibilizantes , Porfirinas , Estudios Prospectivos , Tomografía de Coherencia Óptica , Agudeza VisualRESUMEN
YAG laser vitreolysis is an innovative procedure to treat symptomatic vitreous floaters. The treatment decision is based on taking a comprehensive patient history, thorough clinical examination, realistic expectations, and detailed patient information including risk of the procedure. Manifestation of vitreous opacities and possible subjective impairments are considerably variable. Dynamic changes over time are possible. Therefore, not all vitreous opacities are suitable for laser treatment. A classification according to histoanatomical origin can aid the treatment decision. In comparison to other ophthalmic YAG laser applications, YAG laser vitreolysis differs predominantly by its specific technical equipment requirements. In addition, treatment is more complex and time consuming, requires appropriate experience and knowledge of the surgeon, and should be carried out with utmost care and accuracy.
Asunto(s)
Terapia por Láser , Láseres de Estado Sólido , Humanos , Trastornos de la Visión , Vitrectomía , Cuerpo VítreoRESUMEN
INTRODUCTION: As our population ages and comorbidities rise, ophthalmic surgeons are increasingly faced with patients on anticoagulant therapy or with clotting disorders. The ophthalmic surgeon has to weigh the perioperative risk of haemorrhage when anticoagulation continues against the risk of thromboembolism caused by discontinuation or changing the patient's medication (bridging, switching, cessation). There are currently no guidelines or recommendations. METHODS: A survey was sent to the DOG (German Ophthalmologic Society) divisions and associated surgical organizations to determine the status quo. A questionnaire was sent out and filled out by the different groups of specialists. RESULTS: All four divisions of the DOG and four associated organizations returned completed questionnaires. Surgical interventions were listed that are carried out during anticoagulant therapy without exceptions, as well as interventions that were classified to require medical adjustment. Although the assessments varied, general consensus was achieved regarding interventions not requiring adjustments due to anticoagulants (i.â¯e., intravitreal injection, cataract surgery, laser and corneal operations, simple muscle surgery), and those interventions requiring adjustments in medications (glaucoma operations, complex retina surgery, eye socket surgery, complex surgery of the lid). CONCLUSION: Main result of this survey was the specification of serious bleeding complications which are permanent vision loss and re-operation. They could serve as endpoint parameters for essential future investigations. Nevertheless, this survey makes clear that the decision about an adjustment of anticoagulant medication in ophthalmic surgery is currently made individually and not based on established standards.
Asunto(s)
Cirujanos , Tromboembolia , Anticoagulantes , Alemania , Humanos , Encuestas y CuestionariosAsunto(s)
Nevo Pigmentado , Nevo , Neoplasias de la Coroides , Angiografía con Fluoresceína , Humanos , Lípidos , Neoplasias CutáneasRESUMEN
BACKGROUND: The introduction of full fundus angiography (FAG) for retinal vein occlusion (RVO) has enriched diagnostic imaging; however, it is unclear how much of the retina has to be visualized to evaluate the risk of neovascularization. We investigated the 102° Spectralis camera to assess if imaging beyond the central 102° is necessary. METHODS: In this retrospective study we assessed 80 eyes of 80 patients with RVO to analyze central and peripheral ischemia using the ultra-widefield 102° Spectralis camera. The standard viewer software was used to delineate ischemic areas (IA) and to measure the amount of pixels of IA in correlation to the total amount of pixels in the peripheral image. RESULTS: Among the 80 eyes with RVO there were 51 eyes with ischemic areas (central and/or peripheral), of which IA could be detected in 49 eyes by analyzing a fovea-centered FAG image. The average IA in these 51 eyes was 23.5% of the total image area and 53.7% of disc areas, respectively. DISCUSSION: A fovea-centered FAG image with a 102° angle appears to be sufficient to determine the clinically relevant extent of IA. Old recommendations and imaging methods should be rethought. The 102° Spectralis camera provides a clinically suitable, fast and exact method which might replace old methods to describe and document the extent of ischemia by disc areas.
Asunto(s)
Oclusión de la Vena Retiniana , Vena Retiniana , Angiografía con Fluoresceína , Fondo de Ojo , Humanos , Retina , Estudios RetrospectivosRESUMEN
For many decades, scleral buckling surgery was the only reasonable surgical procedure in eyes with primary rhegmatogenous retinal detachment. In recent years, primary vitrectomy has apparently become the treatment of choice, although evidence from comparative clinical trials is missing. In this article, data from clinical trials and indications for buckling surgery are presented.
Asunto(s)
Desprendimiento de Retina/cirugía , Curvatura de la Esclerótica/métodos , Coroides , Ensayos Clínicos como Asunto , Diseño de Equipo , Humanos , Hidrogel de Polietilenoglicol-Dimetacrilato/administración & dosificación , Inyecciones Intraoculares , Iluminación/instrumentación , Iluminación/métodos , Microcirugia/instrumentación , Microcirugia/métodos , Curvatura de la Esclerótica/instrumentación , Vitrectomía/instrumentación , Vitrectomía/métodosRESUMEN
INTRODUCTION: In 2001 a survey among retinal surgeons regarding the treatment of rhegmatogenous retinal detachment either with scleral buckling methods or primary vitrectomy was performed. Due to the technical progress of vitrectomy and observational systems, it seemed appropriate to renew and update this survey supplemented with current aspects. METHODS: In this study 78 vitreoretinal surgeons from German-speaking countries were surveyed via an anonymous online questionnaire on their treatment decisions for defined retinal detachment constellations. Furthermore, general aspects, such as surgical experience, timing of surgery and anesthesia were queried. The results were compared to the results of 2001. RESULTS: Only 31.1% of the surgeons had performed more than 1000 scleral buckling procedures, whereas 80.8% had performed more than 1000 primary vitrectomies, 72.7% use mainly 23 gauge, 19.5% use 20 gauge and 7.8% use 25 gauge vitrectomy systems. Of the participants 88.5% perform retinal detachment surgery also on weekends and 85.9% in emergency services. In cases of one-hole configuration 73.1% of surgeons would choose treatment with a scleral buckle and only 7.7% with primary vitrectomy. The willingness to perform scleral buckling procedure decreases with coexisting risk factors. In the presence of two adjacent retinal tears but still treatable by scleral buckling, only 56.9% would perform a conventional buckling technique but 33.3% primary vitrectomy. In a more complex retinal hole configuration but still treatable with scleral buckling elements, only 6.4% would chose scleral buckling whereas 71.8% primary vitrectomy. In comparison with the 2001 survey, there is a marked trend in retinal detachment surgery in favor of primary vitrectomy not only in pseudophakic eyes. General anesthesia was the preferred anesthesia method and in a macular-on situation nearly 50% of the responders would perform surgery on the next day. CONCLUSION: The results of our survey confirm an obvious tendency away from buckling surgery towards primary vitrectomy in the treatment of rhegmatogenous retinal detachment.
Asunto(s)
Desprendimiento de Retina , Humanos , Desprendimiento de Retina/cirugía , Curvatura de la Esclerótica , Resultado del Tratamiento , Agudeza Visual , VitrectomíaRESUMEN
BACKGROUND: Due to demographic change and societal transformation the number of elderly persons living in retirement homes is growing in Germany. Access to health care is more complicated in the setting of nursing homes. Different regional studies suggest unmet ophthalmological health care needs in institutionalized elderly people. This study assessed the current ophthalmological health care structure and supply status in nursing homes in Germany. METHODS: This prospective, multicenter cross-sectional study was conducted by 14 study centers in Germany. Elderly people living in 32 nursing homes were included after approval by the local institutional review boards. A standardized examination was performed which included a detailed medical and ocular history, refraction, visual acuity testing, tonometry, biomicroscopy and dilated funduscopy. Unmet ophthalmological health care needs were documented and the data were analyzed descriptively and via logistic regression modelling. RESULTS: A total of 600 participants (434 women and 166 men) aged 50-104 years were examined of which 368 (61%) had ophthalmological conditions requiring treatment. The most prevalent findings were cataracts (315; 53%), disorders of the eyelids (127; 21%), dry eye disease (57; 10%) and posterior capsule opacification (43; 7%). In 63 (11%) of the participants glaucoma was suspected and 55 (9%) of the examined population had a known diagnosis of glaucoma, of whom one third was not on any or on insufficient anti-glaucomatous therapy. 236 (39%) showed signs of age-related macular degeneration (AMD). Only 52% of the examined cohort had been examined by an ophthalmologist within the last 5 years and 39% stated that they would currently not be able to consult an ophthalmologist. Reported barriers were mainly transport and lack of support. CONCLUSION: This study demonstrates considerable unmet ophthalmological health care needs of the institutionalized elderly in Germany. Novel and reformed models of specialist care provision have to be developed.
Asunto(s)
Oftalmopatías/diagnóstico , Oftalmopatías/terapia , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Necesidades y Demandas de Servicios de Salud/estadística & datos numéricos , Hogares para Ancianos/estadística & datos numéricos , Casas de Salud/estadística & datos numéricos , Oftalmología/estadística & datos numéricos , Factores de Edad , Anciano , Anciano de 80 o más Años , Estudios Transversales , Técnicas de Diagnóstico Oftalmológico/estadística & datos numéricos , Oftalmopatías/epidemiología , Femenino , Alemania , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Elective surgery of the vitreoretinal interface is currently the most common reason for vitrectomy in Germany. The evaluation and correct interpretation of spectral domain optical coherence tomography (SD-OCT) images is of great importance but the indications for vitrectomy in macular surgery should be based more on patient symptoms and not only the OCT findings. Watchful waiting is highlighted as an alternative therapeutic option in individual patients. This article addresses a number of aspects and discrepancies between findings and patients' level of suffering based on binocular symptoms. Postoperative retinal thickening and irregular surface of the macula after peeling operations may still allow excellent function and often require no therapeutic measures. The difficulties in differentiating between cystoid macular edema after cataract operations with simultaneous epiretinal gliosis and gliosis as the cause of macular edema are highlighted.
Asunto(s)
Tomografía de Coherencia Óptica , Vitrectomía/métodos , Cirugía Vitreorretiniana/métodos , Espera Vigilante , Extracción de Catarata , Diagnóstico Diferencial , Membrana Epirretinal/diagnóstico , Gliosis/diagnóstico , Humanos , Mácula Lútea/cirugía , Edema Macular/diagnóstico , Satisfacción del Paciente , Complicaciones Posoperatorias/diagnóstico , Remisión Espontánea , Enfermedades de la Retina/cirugía , Trastornos de la Visión/cirugíaRESUMEN
Kranenburg's syndrome is defined as central serous detachment associated with an optic disc pit. We report the interesting and very seldom combination of Kranenburg's syndrome and iris-retinochoroidal-coloboma. Reattachment was achieved after vitrectomy, peeling of epiretinal membranes, laser coagulation adjacent and temporal to the optic disc and gas endotamponade. Coincidence of this syndrome with an iris-retinochoroidal-coloboma is extremely rare. Both coloboma and optic disc pit are based on closure defects during week 6 of embryogenesis.
Asunto(s)
Coriorretinopatía Serosa Central/diagnóstico , Coroides/anomalías , Coloboma/diagnóstico , Iris/anomalías , Disco Óptico/anomalías , Enfermedades del Nervio Óptico/diagnóstico , Retina/anomalías , Adulto , Coriorretinopatía Serosa Central/cirugía , Coroides/cirugía , Coloboma/cirugía , Femenino , Angiografía con Fluoresceína , Estudios de Seguimiento , Humanos , Iris/cirugía , Coagulación con Láser , Disco Óptico/cirugía , Enfermedades del Nervio Óptico/cirugía , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/cirugía , Recurrencia , Reoperación , Retina/cirugía , Microscopía con Lámpara de Hendidura , Síndrome , Tomografía de Coherencia Óptica , VitrectomíaAsunto(s)
Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Neoplasias Pulmonares/diagnóstico , Síndromes Paraneoplásicos Oculares/diagnóstico , Trastornos de la Visión/etiología , Anciano , Carcinoma de Pulmón de Células no Pequeñas/patología , Diagnóstico Diferencial , Progresión de la Enfermedad , Femenino , Angiografía con Fluoresceína , Estudios de Seguimiento , Humanos , Neoplasias Pulmonares/patología , Estadificación de Neoplasias , Oftalmoscopios , Tomografía de Coherencia Óptica , Pruebas del Campo VisualRESUMEN
In ophthalmology many patients undergo surgical treatment who need to take anticoagulant medication due to cardiovascular diseases. The proper handling of these drugs requires both correct assessment of the risk of thromboembolism as well as the rating of the risk of surgery-related hemorrhages. While there are established recommendations for estimation of the risk of thromboembolism based on a large body of prospective randomized trials, data regarding the evaluation of the related complications secondary to ophthalmic surgery are limited. In comparison to other surgical procedures, most interventions in ophthalmic surgery tend to have a relatively low risk of bleeding; therefore, in general there is no need to convert or discontinue anticoagulant drugs in patients undergoing opthalmic surgery. The sparse data available justifying the abrupt termination of anticoagulation are contrary to the approach currently widely distributed in clinical practice. This overview covers the relevant knowledge of the perioperative use of anticoagulant drugs. In addition, the data on the risk of hemorrhage in ophthalmological procedures are presented and discussed.
Asunto(s)
Anticoagulantes/administración & dosificación , Procedimientos Quirúrgicos Oftalmológicos/estadística & datos numéricos , Inhibidores de Agregación Plaquetaria/administración & dosificación , Tromboembolia/epidemiología , Tromboembolia/prevención & control , Procedimientos Innecesarios/estadística & datos numéricos , Causalidad , Medicina Basada en la Evidencia , Humanos , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/prevención & control , Prevalencia , Factores de Riesgo , Resultado del TratamientoRESUMEN
BACKGROUND: To date, there is no consensus about the management of persistent cystoid macular edema (CME) following vitrectomy. The aim of this study was to evaluate the efficacy and safety of intravitreal dexamethasone implants for the treatment of postoperative CME following vitrectomy. MATERIAL AND METHODS: In this multicenter study we retrospectively reviewed the data of 24 patients (25 eyes) who had been treated with intravitreal dexamethasone (Ozurdex®) for the management of persistent postoperative CME following pars plana vitrectomy. The main outcome measure was central retinal thickness (CRT in µm) as assessed by spectral domain optical coherence tomography (SD-OCT). Secondary outcome measures included change in best corrected visual acuity (BCVA) and the presence of metamorphopsia. RESULTS: All 19 eyes which were postoperatively examined within 4-8 weeks after implantation showed a significant decrease in CRT (mean 564 µm to 315 µm) and a reduction of metamorphopsias. Within the same period of time the BCVA improved in 15 out of 19 eyes (79%) which corresponds to an average visual improvement from 0.69 logMAR to 0.46 logMAR (P <0.0001). In eyes examined after 10-16 weeks a slight increase in the average CRT of 351 µm was observed, whereas the BCVA improved to 0.28 logMAR. After 4 months a decrease in average BCVA was noted. Out of 25 eyes 12 required further dexamethasone implantations between 1 and 4 times within the investigation period. The first repeat injections were performed an average of 7.3 months after the initial treatment. CONCLUSION: Our results suggest that intravitreal dexamethasone is a safe and effective treatment option for persistent CME following vitrectomy.
Asunto(s)
Dexametasona/administración & dosificación , Edema Macular/tratamiento farmacológico , Complicaciones Posoperatorias/tratamiento farmacológico , Vitrectomía , Anciano , Enfermedad Crónica , Implantes de Medicamentos , Femenino , Estudios de Seguimiento , Humanos , Edema Macular/diagnóstico , Masculino , Complicaciones Posoperatorias/diagnóstico , Retina/efectos de los fármacos , Retratamiento , Estudios Retrospectivos , Tomografía de Coherencia Óptica , Resultado del Tratamiento , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/tratamiento farmacológico , Agudeza Visual/efectos de los fármacosRESUMEN
BACKGROUND: The intravitreal administration of vascular endothelial growth factor (VEGF) inhibitors is the gold standard in the treatment of exudative age-related macular degeneration (AMD) but the possible risks of systemic, particularly cardiovascular side effects are still discussed. PATIENTS AND METHODS: We prospectively followed 111 patients at the University Hospital in Göttingen with exudative AMD and intravitreal ocular treatment with bevacizumab and ranibizumab during the upload phase of 3 months using a questionnaire for documentation of possible cardiovascular events. RESULTS: In 5 out of 111 patients angina pectoris was observed and in 6 patients the antihypertensive medication had to be increased. No differences were found between bevacizumab and ranibizumab. A patient with pre-existing cardiovascular diseases suffered a stroke in the upload phase but no thromboembolic events were observed in the other patients. CONCLUSION: In this small but prospective clinical study no increased risk for cardiovascular events during the upload phase of the VEGF inhibitors ranibizumab and bevacizumab could be detected when taking the age and pre-existing cardiovascular diseases into consideration.